{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T22:17:00Z","timestamp":1791065820642,"version":"4.1.0"},"reference-count":43,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2000,2,1]],"date-time":"2000-02-01T00:00:00Z","timestamp":949363200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Neuropeptides"],"published-print":{"date-parts":[[2000,2]]},"DOI":"10.1054\/npep.1999.0793","type":"journal-article","created":{"date-parts":[[2002,9,19]],"date-time":"2002-09-19T15:33:28Z","timestamp":1032449608000},"page":"69-75","source":"Crossref","is-referenced-by-count":17,"title":["Mu and delta opioid receptor regulation of pro-opiomelanocortin peptide secretion from the rat neurointermediate pituitary in vitro"],"prefix":"10.1054","volume":"34","author":[{"given":"J.A.","family":"Carr","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.T.","family":"Lovering","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1054\/npep.1999.0793_RF1","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1016\/0024-3205(78)90667-7","article-title":"\u03b2-endorphin-like immunoreactivity in plasma, pituitaries and hypothalamus of rats following treatment with opiates","volume":"23","author":"Holt","year":"1978","journal-title":"Life Sci"},{"key":"10.1054\/npep.1999.0793_RF2","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1007\/BF02896854","article-title":"Down-regulation of proopiomelanocortin synthesis and beta-endorphin utilization in hypothalamus of morphine-tolerant rats","volume":"1","author":"Mochetti","year":"1989","journal-title":"J Mol Neurosci"},{"key":"10.1054\/npep.1999.0793_RF3","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/0006-8993(90)90066-K","article-title":"Effects of morphine treatment on pro-opiomelanocortin systems in rat brain","volume":"519","author":"Bronstein","year":"1990","journal-title":"Brain Res"},{"key":"10.1054\/npep.1999.0793_RF4","doi-asserted-by":"crossref","first-page":"2304","DOI":"10.1111\/j.1471-4159.1993.tb03518.x","article-title":"Effects of chronic morphine treatment on \u03b2-endorphin-related peptides in the caudal medulla and spinal cord","volume":"60","author":"Bronstein","year":"1993","journal-title":"J Neurochem"},{"key":"10.1054\/npep.1999.0793_RF5","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/0143-4179(93)90087-Q","article-title":"Opioid regulation of proopiomelanocortin (POMC) gene expression in the rat brain as studied by in situ hybridization","volume":"25","author":"Garcia de Yebenes","year":"1993","journal-title":"Neuropeptides"},{"key":"10.1054\/npep.1999.0793_RF6","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/0169-328X(96)00084-8","article-title":"Effect of morphine on proopiomelanocortin gene expression and peptide levels in the hypothalamus","volume":"41","author":"Wardlaw","year":"1996","journal-title":"Brain Res Mol Brain Res"},{"key":"10.1054\/npep.1999.0793_RF7","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0169-328X(97)00348-3","article-title":"Proopiomelanocortin (POMC) mRNA expression: Distribution and region-specific down-regulation by chronic morphine in female guinea pig hypothalamus","volume":"55","author":"Fang","year":"1998","journal-title":"Brain Res Mol Brain Res"},{"key":"10.1054\/npep.1999.0793_RF8","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/0024-3205(75)90243-X","article-title":"Some thoughts on the significance of enkephalin, the endogenous ligand","volume":"17","author":"Kosterlitz","year":"1975","journal-title":"Life Sci"},{"key":"10.1054\/npep.1999.0793_RF9","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1210\/endo-84-1-20","article-title":"MSH activity in plasma and pituitaries of rats after various treatments","volume":"84","author":"Kastin","year":"1969","journal-title":"Endocrinology"},{"key":"10.1054\/npep.1999.0793_RF10","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1016\/0024-3205(79)90153-X","article-title":"Effects of morphine and \u03b2-endorphin on basal and elevated levels of \u03b1-MSH and vasopressin","volume":"24","author":"Van Wimersma Greidanus","year":"1979","journal-title":"Life Sci"},{"key":"10.1054\/npep.1999.0793_RF11","doi-asserted-by":"crossref","first-page":"1881","DOI":"10.1016\/S0024-3205(96)00535-8","article-title":"Influence of acute and chronic morphine or stadol on the secretion of adrenocorticotrophin and its hypothalamic releasing hormone in the rat","volume":"59","author":"El Daly","year":"1996","journal-title":"Life Sci"},{"key":"10.1054\/npep.1999.0793_RF12","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1203\/00006450-199703000-00018","article-title":"Morphine stimulates adrenocorticotropin and cortisol release in the late-term ovine fetus","volume":"41","author":"Taylor","year":"1997","journal-title":"Pediatr Res"},{"key":"10.1054\/npep.1999.0793_RF13","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1139\/y80-057","article-title":"Effects of different opiate agonists on melanocyte-stimulating hormone release: in vivo and in vitro studies","volume":"58","author":"Celis","year":"1980","journal-title":"Can J Physiol Pharmacol"},{"key":"10.1054\/npep.1999.0793_RF14","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/0167-0115(93)90418-8","article-title":"Effects of the enkephalin analog (D -Met2,Pro5)-enkephalinamide on \u03b1-melanocyte-stimulating hormone secretion","volume":"47","author":"Carr","year":"1993","journal-title":"Reg Peptides"},{"key":"10.1054\/npep.1999.0793_RF15","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/0006-8993(86)91346-6","article-title":"Opiate receptors in rat pituitary are confined to the neural lobe and are exclusively kappa","volume":"382","author":"Herkenham","year":"1986","journal-title":"Brain Res"},{"key":"10.1054\/npep.1999.0793_RF16","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1016\/0306-4522(90)90095-L","article-title":"Opioid receptor subtypes in the supraoptic nucleus and posterior pituitary gland of morphine-tolerant rats","volume":"37","author":"Sumner","year":"1990","journal-title":"Neurosci"},{"key":"10.1054\/npep.1999.0793_RF17","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/0304-3940(92)90407-X","article-title":"Pregnancy alters the density of opioid binding sites in the supraoptic nucleus and posterior pituitary gland of rats","volume":"137","author":"Sumner","year":"1992","journal-title":"Neurosci Lett"},{"key":"10.1054\/npep.1999.0793_RF18","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1111\/j.1365-2826.1994.tb00554.x","article-title":"Characterization of opioid binding sites in the neural and intermediate lobe of the rat pituitary gland by quantitative receptor autoradiography","volume":"6","author":"Boersma","year":"1994","journal-title":"J Neuroendocrinol"},{"key":"10.1054\/npep.1999.0793_RF19","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/0143-4179(88)90032-7","article-title":"Corticotropin-releasing factor (CRF) and neurotransmitters modulate melanotropic peptide release from rat neurointermediate pituitary in vitro","volume":"12","author":"Saland","year":"1988","journal-title":"Neuropeptides"},{"key":"10.1054\/npep.1999.0793_RF20","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/0143-4179(91)90121-X","article-title":"Interaction of corticotropin-releasing factor (CRF) and alpha-helical CRF on rat neurointermediate lobes: in vitro studies","volume":"19","author":"Saland","year":"1991","journal-title":"Neuropeptides"},{"key":"10.1054\/npep.1999.0793_RF21","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1016\/0196-9781(92)90049-9","article-title":"Benzodiazepine suppression of corticotropin-releasing factor (CRF)-induced beta-endorphin release from rat neurointermediate pituitary","volume":"13","author":"Saland","year":"1992","journal-title":"Peptides"},{"key":"10.1054\/npep.1999.0793_RF22","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1038\/194495a0","article-title":"Preparation of131I-labeled growth hormone of high specific activity","volume":"194","author":"Hunter","year":"1962","journal-title":"Nature"},{"key":"10.1054\/npep.1999.0793_RF23","doi-asserted-by":"crossref","first-page":"318","DOI":"10.3181\/00379727-177-41950","article-title":"Changes in hypothalamic and pituitary content of immunoreactive \u03b1-melanocyte-stimulating hormone during the gestational and postpartum periods in the rat","volume":"177","author":"Khorram","year":"1984","journal-title":"Proc Soc Exp Biol Med"},{"key":"10.1054\/npep.1999.0793_RF24","first-page":"160","article-title":"Dopaminergic agents selectively alter the post-translational processing of beta-endorphin in the intermediate pituitary of the rat","volume":"243","author":"Millington","year":"1987","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1054\/npep.1999.0793_RF25","first-page":"E235","article-title":"The role of pituitary \u03b2-endorphin in mediating corticotropin-releasing factor-induced antinociception","volume":"258","author":"Hargreaves","year":"1990","journal-title":"Am J Physiol"},{"key":"10.1054\/npep.1999.0793_RF26","doi-asserted-by":"crossref","first-page":"168","DOI":"10.3181\/00379727-176-41858","article-title":"Differential effects of adrenergic agents on plasma levels of immunoreactive \u03b2-endorphin and \u03b1-melanotropin in rats","volume":"176","author":"Pettibone","year":"1984","journal-title":"Proc Soc Exp Biol Med"},{"key":"10.1054\/npep.1999.0793_RF27","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1126\/science.2858918","article-title":"Methionine and leucine enkephalin in rat neurohypophysis: different responses to osmotic stimuli and T2 toxin","volume":"228","author":"Zamir","year":"1985","journal-title":"Science"},{"key":"10.1054\/npep.1999.0793_RF28","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1210\/endo-122-4-1321","article-title":"Dynorphin A inhibits and naloxone increases the electrically stimulated release of oxytocin but not vasopressin from the terminals of the neural lobe","volume":"122","author":"Bondy","year":"1988","journal-title":"Endocrinology"},{"key":"10.1054\/npep.1999.0793_RF29","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1093\/oxfordjournals.bmb.a071787","article-title":"Classification of opioid receptors","volume":"39","author":"Paterson","year":"1983","journal-title":"Br Med Bull"},{"key":"10.1054\/npep.1999.0793_RF30","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1111\/j.1432-1033.1990.tb15531.x","article-title":"Characterisation and visualisation of [3H]dermorphin binding to mu opioid receptors in the rat brain. Combined high selectivity and affinity in a natural peptide agonist for the morphine (mu) receptor","volume":"189","author":"Amiche","year":"1990","journal-title":"Eur J Biochem"},{"key":"10.1054\/npep.1999.0793_RF31","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1111\/j.1471-4159.1985.tb08802.x","article-title":"Differences in binding properties of mu and delta opioid receptor subtypes from rat brain: Kinetic analysis and effects of ions","volume":"44","author":"Zajac","year":"1985","journal-title":"J Neurochem"},{"key":"10.1054\/npep.1999.0793_RF32","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/0143-4179(87)90048-5","article-title":"Characterization of dermorphin binding to membranes of rat brain and heart","volume":"9","author":"Krumins","year":"1987","journal-title":"Neuropeptides"},{"key":"10.1054\/npep.1999.0793_RF33","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1111\/j.2042-7158.1981.tb13854.x","article-title":"The in vitro pharmacology of D-Met2, Pro5- enkephalinamide","volume":"33","author":"R\u00f3nai","year":"1981","journal-title":"J Pharm Pharmacol"},{"key":"10.1054\/npep.1999.0793_RF34","doi-asserted-by":"crossref","first-page":"2370","DOI":"10.1021\/jm00161a037","article-title":"Design and synthesis of conformationally constrained somatostatin analogues with high potency and specificity for \u03bc opioid receptors","volume":"29","author":"Pelton","year":"1986","journal-title":"J Med Chem"},{"key":"10.1054\/npep.1999.0793_RF35","first-page":"521","article-title":"Opioids act on mu receptors to stimulate \u03b2-endorphin secretion from rat neurointermediate lobes in vitro","volume":"80","author":"Carr","year":"1998","journal-title":"Endocrine Soc Abstr"},{"key":"10.1054\/npep.1999.0793_RF36","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/0006-8993(77)90877-0","article-title":"Opiate receptor binding in the pituitary gland","volume":"124","author":"Simantov","year":"1977","journal-title":"Brain Res"},{"key":"10.1054\/npep.1999.0793_RF37","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/0304-3940(85)90397-0","article-title":"Opioid binding in a rat neurohypophysial fraction enriched in oxytocin and vasopressin nerve endings","volume":"61","author":"Falke","year":"1985","journal-title":"Neurosci Lett"},{"key":"10.1054\/npep.1999.0793_RF38","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1046\/j.1365-2826.1996.53210.x","article-title":"Evidence for multiple opioid receptors in the human posterior pituitary","volume":"8","author":"Jordan","year":"1996","journal-title":"J Neuroendocrinol"},{"key":"10.1054\/npep.1999.0793_RF39","first-page":"71","article-title":"\u03bc-specific opioid compounds affect secretion from peptidergic nerve terminals without altering their electrophysiological properties","volume":"22","author":"Coccia","year":"1996","journal-title":"Soc Neurosci Abstr"},{"key":"10.1054\/npep.1999.0793_RF40","first-page":"677","article-title":"\u03bc-selective opioids block calcium channels in peptidergic neurohypophysial nerve terminals","volume":"23","author":"Coccia","year":"1997","journal-title":"Soc Neurosci Abstr"},{"key":"10.1054\/npep.1999.0793_RF41","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1159\/000124984","article-title":"Opioid-noradrenergic interactions in the neurohypophysis. I. Differential opioid receptor regulation of oxytocin, vasopressin and noradrenaline release","volume":"48","author":"Zhao","year":"1988","journal-title":"Neuroendocrinology"},{"key":"10.1054\/npep.1999.0793_RF42","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1159\/000124168","article-title":"Effects of opioid agonists and antagonists on oxytocin and vasopressin release in vitro","volume":"41","author":"Bicknell","year":"1985","journal-title":"Neuroendocrinology"},{"key":"10.1054\/npep.1999.0793_RF43","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1111\/j.1365-2826.1990.tb00414.x","article-title":"Effects of different opioid receptor antagonists on the electrically-evoked release of endogenous dopamine from the isolated neural lobe of the rat pituitary gland in vitro","volume":"2","author":"Rack\u00e9","year":"1990","journal-title":"J Neuroendocrinol"}],"container-title":["Neuropeptides"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S014341799990793X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S014341799990793X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,4,11]],"date-time":"2019-04-11T18:23:48Z","timestamp":1555007028000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S014341799990793X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2000,2]]},"references-count":43,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2000,2]]}},"alternative-id":["S014341799990793X"],"URL":"https:\/\/doi.org\/10.1054\/npep.1999.0793","relation":{},"ISSN":["0143-4179"],"issn-type":[{"value":"0143-4179","type":"print"}],"subject":[],"published":{"date-parts":[[2000,2]]}}}